NDM-1 Positive Organisms

We’re hearing more and more these days about antibiotic-resistant bacteria. The most recent “superbug” in the news is New Delhi metallo-beta-lactamase (NDM-1), which is part of a family of Extended Spectrum Beta-Lactamase (ESBL) producing bacteria. These are newly identified antibiotic-resistant strains of Escherichia coli, Enterobacter cloacae or Klebsiella pneumoniae, and they are a great cause for concern, especially in clinical settings like hospitals or long-term care facilities.

These superbugs are often resistant to an extremely wide array of antibiotics, which severely limits a clinician’s therapeutic options with infected patients. With fewer and fewer effective antibiotic options available, healthcare institutions need more effective disinfectants with shorter exposure times and better surface hygiene practices. These will become important weapons against superbugs.

ATS Labs has obtained the most recent NDM-1 strains and is ready to help show that your product is effective against the new superbugs. In fact, we have an extensive library of antibiotic-resistant organism strains including Methicillin-resistant Staphylococcus aureus (MRSA), Vancomycin-resistant Enterococcus (VRE) and ESBL producing organisms. We even have E. coli sequence type ST131, another new ESBL strain.

These organisms are important for your product’s label. There is a growing demand for effective disinfectants and sanitizers that can kill these antibiotic-resistant bacteria. ATS Labs can help you meet this market demand by developing efficacy data to support the successful registration of your products.